Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 55, Issue 12, Pages 2278-2290
Publisher
Wiley
Online
2016-02-21
DOI
10.1002/mc.22468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
- (2013) Masaki Shiota et al. CURRENT CANCER DRUG TARGETS
- Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis
- (2013) Tzu-Hua Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
- (2013) T-H Lin et al. Cell Death & Disease
- A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
- (2013) J. D. Joseph et al. Cancer Discovery
- Overcoming mutation-based resistance to antiandrogens with rational drug design
- (2013) Minna D Balbas et al. eLife
- New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
- (2012) Kuo-Pao Lai et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer
- (2012) Y. Y. Zaytseva et al. CANCER RESEARCH
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
- (2011) C. J. Ryan et al. CLINICAL CANCER RESEARCH
- The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction
- (2010) Jinrong Cheng et al. CANCER BIOLOGY & THERAPY
- Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice
- (2010) Soichiro Murata et al. CANCER SCIENCE
- Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
- (2010) A. Vazquez-Martin et al. CELL PROLIFERATION
- Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
- (2010) Paul L. Nguyen et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
- (2010) Y Niu et al. ONCOGENE
- Androgen Receptor Promotes Hepatitis B Virus-Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
- (2010) M. H. Wu et al. Science Translational Medicine
- Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
- (2009) Toshiro Migita et al. JNCI-Journal of the National Cancer Institute
- Ligand-independent activation of the androgen receptor by insulin-like growth factor-i and the role of the MAPK pathway in skeletal muscle cells
- (2009) Hye Jin Kim et al. MOLECULES AND CELLS
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
- (2008) Kamilla Malinowska et al. ENDOCRINE-RELATED CANCER
- Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
- (2008) Weng–Lung Ma et al. GASTROENTEROLOGY
- Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
- (2008) Michelangelo Fiorentino et al. LABORATORY INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now